Expression of multiple membrane-associated phospholipase A1 beta transcript variants and lysophosphatidic acid receptors in Ewing tumor cells

Molecular Biology Reports

Volumn 38, Issue 7, 2011, Pages 4619-4628

  Schmiedel, Benjamin Joachim ^a   Hutter, Christoph ^a   Hesse, Manuela ^a   Staege, Martin Sebastian ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Ewing tumors; Gene expression; Lipase I; Lysophosphatidic acid signaling; Splice variants

Indexed keywords

LYSOPHOSPHATIDIC ACID RECEPTOR; PHOSPHATIDIC ACID SPECIFIC MEMBRANE ASSOCIATED PHOSPHOLIPASE A1 BETA; PHOSPHOLIPASE A1; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; EWING SARCOMA; HUMAN; HUMAN CELL; MOLECULAR CLONING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR CELL;

ALTERNATIVE SPLICING; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CELL MEMBRANE; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPASE; PHOSPHOLIPASES A1; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA SPLICE SITES; RNA, MESSENGER; SARCOMA, EWING; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 80052468890     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0595-z     Document Type: Article

References (58)

1. MS Staege D Max 2009 Genetics and epigenetics of the TET-ETS translocation network Gene Epigenetics 2 1 15 1:CAS:528:DC%2BC3cXksFeht74%3D
2. R Hühn MS Staege M Hesse B Liebig SE Burdach 2009 Cleavage of the Ewing tumour-specific EWSR1-FLI1 mRNA by hammerhead ribozymes Anticancer Res 29 1901 1908 19528446
3. R Todorova 2009 In vitro interaction between the N-terminus of the Ewing's sarcoma protein and the subunit of RNA polymerase II hsRPB7 Mol Biol Rep 36 1269 1274 18607770 10.1007/s11033-008-9308-2 1:CAS:528:DC%2BD1MXmtlOns7k%3D
4. C Pfeifle K Reinhardt S Heins S Burdach MS Staege 2009 Development and characterization of HAT-sensitive Ewing tumour cells for immunotherapy Anticancer Res 29 4489 44896 20032396 1:CAS:528:DC%2BC3cXptlelug%3D%3D
5. MS Staege UE Hattenhorst UE Neumann C Hutter S Foja S Burdach 2003 DNA-microarrays as tools for the identification of tumor specific gene expression profiles: applications in tumor biology, diagnosis and therapy Klin Padiatr 215 135 139 12838936 10.1055/s-2003-39371 1:STN:280: DC%2BD3szhtVGntw%3D%3D
6. MS Staege G Hansen G Baersch S Burdach 2004 Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy Pediatr Blood Cancer 43 23 34 15170886 10.1002/pbc.20013
7. MS Staege C Hutter I Neumann S Foja UE Hattenhorst G Hansen D Afar SE Burdach 2004 DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets Cancer Res 64 8213 8221 15548687 10.1158/0008-5472.CAN-03-4059 1:CAS:528: DC%2BD2cXpvVGluro%3D
8. JL Foell M Hesse I Volkmer BJ Schmiedel I Neumann MS Staege 2008 Membrane-associated phospholipase A1 beta (LIPI) Is an Ewing tumour-associated cancer/testis antigen Pediatr Blood Cancer 51 228 234 18435455 10.1002/pbc.21602
9. N Riggi ML Suvà C De Vito P Provero JC Stehle K Baumer L Cironi M Janiszewska T Petricevic D Suvà S Tercier JM Joseph L Guillou I Stamenkovic 2010 EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells Genes Dev 24 916 932 20382729 10.1101/gad.1899710 1:CAS:528:DC%2BC3cXmtleht7g%3D
10. MJ Scanlan CM Gordon B Williamson SY Lee YT Chen E Stockert A Jungbluth G Ritter D Jäger E Jäger A Knuth LJ Old 2002 Identification of cancer/testis genes by database mining and mRNA expression analysis Int J Cancer 98 485 492 11920606 10.1002/ijc.10276 1:CAS:528:DC%2BD38XitlSrtbY%3D
11. XY Wen RA Hegele J Wang DY Wang J Cheung M Wilson M Yahyapour Y Bai L Zhuang J Skaug TK Young PW Connelly BF Koop LC Tsui AK Stewart 2003 Identification of a novel lipase gene mutated in lpd mice with hypertriglyceridemia and associated with dyslipidemia in humans Hum Mol Genet 12 1131 1143 12719377 10.1093/hmg/ddg124 1:CAS:528:DC%2BD3sXkt1Wrtbs%3D
12. T Hiramatsu H Sonoda Y Takanezawa R Morikawa M Ishida K Kasahara Y Sanai R Taguchi J Aoki H Arai 2003 Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPA-PLA1beta J Biol Chem 278 49438 49447 12963729 10.1074/jbc.M213018200 1:CAS:528: DC%2BD3sXptlGrt7w%3D
13. MS Staege M Hesse D Max 2010 Lipases and related molecules in cancer Cancer Growth Metastasis 3 11 20 10.4137/CGM.S2816 1:CAS:528: DC%2BC3cXltFWit7o%3D
14. GJ Botma M Heuveling JM Lamers H Jansen AJ Verhoeven 2007 Cloning, expression, and promoter analysis of hepatic lipase derived from human hyperplastic adrenals: evidence for alternative mRNA splicing Cell Biochem Biophys 47 118 149
15. PK Larsson Forsell BP Kennedy HE Claesson 1999 The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene Eur J Biochem 262 575 585 10336645 10.1046/j.1432-1327.1999.00418.x 1:STN:280:DyaK1M3mvFSgsQ%3D%3D
16. H Sonoda J Aoki T Hiramatsu M Ishida K Bandoh Y Nagai R Taguchi K Inoue H Arai 2002 A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid J Biol Chem 277 34254 34263 12063250 10.1074/jbc. M201659200 1:CAS:528:DC%2BD38Xnt1Squrw%3D
17. Y Nagai J Aoki T Sato K Amano Y Matsuda H Arai K Inoue 1999 An alternative splicing form of phosphatidylserine-specific phospholipase A1 that exhibits lysophosphatidylserine-specific lysophospholipase activity in humans J Biol Chem 274 11053 11059 10196188 10.1074/jbc.274.16.11053 1:CAS:528: DyaK1MXis1GmsLw%3D
18. J Lu J Li C Ji W Yu Z Xu S Huang 2008 Expression of lipoprotein lipase associated with lung adenocarcinoma tissues Mol Biol Rep 35 59 63 17347923 10.1007/s11033-006-9053-3
19. W Li JL Blankman BF Cravatt 2007 A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases J Am Chem Soc 129 9594 9595 17629278 10.1021/ja073650c 1:CAS:528:DC%2BD2sXns1CntbY%3D
20. JL Foell I Volkmer C Giersberg M Kornhuber G Horneff MS Staege 2008 Loss of detectability of Charcot-Leyden crystal protein transcripts in blood cells after treatment with dimethyl sulfoxide J Immunol Methods 339 99 103 18789335 10.1016/j.jim.2008.08.006 1:CAS:528:DC%2BD1cXht1SntLjN
21. I Neumann JL Foell M Bremer I Volkmer D Korholz S Burdach MS Staege 2010 Retinoic acid enhances sensitivity of neuroblastoma cells for imatinib mesylate Pediatr Blood Cancer 55 464 470 20658618 10.1002/pbc.22603
22. Li J, Neumann I, Volkmer I, Staege MS (2010) Down-regulation of achaete-scute complex homolog 1 (ASCL1) in neuroblastoma cells induces up-regulation of insulin-like growth factor 2 (IGF2). Mol Biol Rep (in press)
23. JD Thompson DG Higgins TJ Gibson 1994 CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res 22 4673 4680 7984417 10.1093/nar/22.22.4673 1:CAS:528: DyaK2MXitlSgu74%3D
24. K Arnold L Bordoli J Kopp T Schwede 2006 The SWISS-MODEL Workspace: a web-based environment for protein structure homology modelling Bioinformatics 22 195 201 16301204 10.1093/bioinformatics/bti770 1:CAS:528:DC%2BD28XovVCltw%3D%3D
25. MG Reese FH Eeckman D Kulp D Haussler 1997 Improved splice site detection in genie J Comp Biol 4 311 323 10.1089/cmb.1997.4.311 1:CAS:528: DyaK2sXls1Whtbc%3D
26. A Roussel Y Yang F Ferrato R Verger C Cambillau M Lowe 1998 Structure and activity of rat pancreatic lipase-related protein 2 J Biol Chem 273 32121 32128 9822688 10.1074/jbc.273.48.32121 1:CAS:528:DyaK1cXnvVeltb8%3D
27. M Ouchida T Ohno Y Fujimura VN Rao ES Reddy 1995 Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts Oncogene 11 1049 1054 7566963 1:CAS:528:DyaK2MXosFyitbs%3D
28. G Lambert JR Bertrand E Fattal F Subra H Pinto-Alphandary C Malvy C Auclair P Couvreur 2000 EWS fli-1 antisense nanocapsules inhibits Ewing sarcoma-related tumor in mice Biochem Biophys Res Commun 279 401 406 11118299 10.1006/bbrc.2000.3963 1:CAS:528:DC%2BD3cXovVCntL8%3D
29. Y Matsumoto K Tanaka F Nakatani T Matsunobu S Matsuda Y Iwamoto 2001 Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes Br J Cancer 84 768 775 11259090 10.1054/bjoc.2000.1652 1:CAS:528:DC%2BD3MXivVGrtrY%3D
30. N Toub JR Bertrand C Malvy E Fattal P Couvreur 2006 Antisense oligonucleotide nanocapsules efficiently inhibit EWS-Fli1 expression in a Ewing's sarcoma model Oligonucleotides 16 158 168 16764539 10.1089/oli.2006.16. 158 1:CAS:528:DC%2BD28XlsV2rs7w%3D
31. S Mateo-Lozano PC Gokhale VA Soldatenkov A Dritschilo OM Tirado V Notario 2006 Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma Clin Cancer Res 12 6781 6790 17121899 10.1158/1078-0432.CCR-06- 0609 1:CAS:528:DC%2BD28Xht1elsLzJ
32. H Elhamess JR Bertrand J Maccario A Maksimenko C Malvy 2009 Antitumor vectorized oligonucleotides in a model of Ewing sarcoma: unexpected role of nanoparticles Oligonucleotides 19 255 264 19732024 10.1089/oli.2009.0197 1:CAS:528:DC%2BD1MXhtFCjtb3E
33. CL Mackall EH Rhee EJ Read HM Khuu SF Leitman D Bernstein M Tesso LM Long D Grindler M Merino W Kopp M Tsokos JA Berzofsky LJ Helman 2008 A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas Clin Cancer Res 14 4850 4858 18676758 10.1158/1078-0432.CCR-07-4065 1:CAS:528:DC%2BD1cXpt1ejurs%3D
34. J Aoki A Inoue K Makide N Saiki H Arai 2007 Structure and function of extracellular phospholipase A1 belonging to the pancreatic lipase gene family Biochimie 89 197 204 17101204 10.1016/j.biochi.2006.09.021 1:CAS:528: DC%2BD2sXhtlaqs7s%3D
35. RL Strausberg EA Feingold LH Grouse JG Derge RD Klausner FS Collins L Wagner CM Shenmen GD Schuler SF Altschul B Zeeberg KH Buetow CF Schaefer NK Bhat RF Hopkins H Jordan T Moore SI Max J Wang F Hsieh L Diatchenko K Marusina AA Farmer GM Rubin L Hong M Stapleton MB Soares MF Bonaldo TL Casavant TE Scheetz MJ Brownstein TB Usdin S Toshiyuki P Carninci C Prange SS Raha NA Loquellano GJ Peters RD Abramson SJ Mullahy SA Bosak PJ McEwan KJ McKernan JA Malek PH Gunaratne S Richards KC Worley S Hale AM Garcia LJ Gay SW Hulyk DK Villalon DM Muzny EJ Sodergren X Lu RA Gibbs J Fahey E Helton M Ketteman A Madan S Rodrigues A Sanchez M Whiting A Madan AC Young Y Shevchenko GG Bouffard RW Blakesley JW Touchman ED Green MC Dickson AC Rodriguez J Grimwood J Schmutz RM Myers YS Butterfield MI Krzywinski U Skalska DE Smailus A Schnerch JE Schein SJ Jones MA Marra MammalianGeneCollectionProgram Team 2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences Proc Natl Acad Sci USA 99 16899 16903 12477932 10.1073/pnas.242603899
36. LC Chan W Peters Y Xu J Chun RV Farese Jr S Cases 2007 LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA) J Leukoc Biol 82 1193 1200 17709403 10.1189/jlb.0407221 1:CAS:528:DC%2BD2sXht1Kqsb3K
37. Y Xu DC Gaudette JD Boynton A Frankel XJ Fang A Sharma J Hurteau G Casey A Goodbody A Mellors, et al. 1995 Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients Clin Cancer Res 1 1223 1232 9815916 1:STN:280:DyaK1M%2FjsV2gtg%3D%3D
38. K Bandoh J Aoki A Taira M Tsujimoto H Arai K Inoue 2000 Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors FEBS Lett 478 159 165 10922489 10.1016/S0014-5793(00)01827-5 1:CAS:528:DC%2BD3cXltVGrt7o%3D
39. S Nakane S Oka S Arai K Waku Y Ishima A Tokumura T Sugiura 2002 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain Arch Biochem Biophys 402 51 58 12051682 10.1016/S0003-9861(02)00038-3 1:CAS:528:DC%2BD38XktlGru7k%3D
40. TL Shan K Li ZL Tang SL Yang YH Ma WJ Guan DZ Guo 2009 Full-length coding sequences, polymorphism and chromosomal localizations of the porcine EDG4 and EDG7 genes Mol Biol Rep 36 751 756 18379896 10.1007/s11033-008-9239-y 1:CAS:528:DC%2BD1MXisFSkt74%3D
41. SA Kumar X Hu M Brown B Kuschak TA Hernandez JB Johnston SB Gibson 2009 Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression Leuk Lymphoma 50 2038 2048 19860625 10.3109/10428190903275586 1:CAS:528:DC%2BD1MXhsFChsr7F
42. T Yamada S Yano H Ogino K Ikuta S Kakiuchi M Hanibuchi T Kanematsu T Taniguchi Y Sekido S Sone 2008 Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2 Cancer Sci 99 1603 1610 18754873 10.1111/j.1349-7006.2008.00848.x 1:CAS:528:DC%2BD1cXhtFKnur7J
43. D Shida J Kitayama H Yamaguchi Y Okaji NH Tsuno T Watanabe Y Takuwa H Nagawa 2003 Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1 Cancer Res 63 1706 1711 12670925 1:CAS:528:DC%2BD3sXisFahs7w%3D
44. Z Zhou J Niu Z Zhang 2009 The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells (2010) Mol Biol Rep 37 2675 2686 19757175 10.1007/s11033-009-9798-6
45. CI Lin CN Chen MT Huang SJ Lee CH Lin CC Chang H Lee 2008 Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms Cell Signal 20 1804 1814 18627789 10.1016/j.cellsig.2008.06.008 1:CAS:528:DC%2BD1cXhtVejt7rM
46. Sumida H, Noguchi K, Kihara Y, Abe M, Yanagida K, Hamano F, Sato S, Tamaki K, Morishita Y, Kano MR, Iwata C, Miyazono K, Sakimura K, Shimizu T, Ishii S (2019) LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. Blood (in press)
47. J Ewing 1921 Diffuse endothelioma of bone Proc N Y Pathol Soc 21 17 24
48. GH Richter S Plehm A Fasan S Rössler R Unland IM Bennani-Baiti M Hotfilder D Löwel I von Luettichau I Mossbrugger L Quintanilla-Martinez H Kovar MS Staege C Müller-Tidow S Burdach 2009 EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation Proc Natl Acad Sci USA 106 5324 5329 19289832 10.1073/pnas.0810759106 1:CAS:528:DC%2BD1MXksVSiur0%3D
49. JL Tanyi AJ Morris JK Wolf X Fang Y Hasegawa R Lapushin N Auersperg YJ Sigal RA Newman EA Felix EN Atkinson GB Mills 2003 The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer Cancer Res 63 1073 1082 12615725 1:CAS:528:DC%2BD3sXhs1agt7c%3D
50. D Max M Hesse I Volkmer MS Staege 2009 High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors Cancer Sci 100 2383 2389 19793082 10.1111/j.1349-7006.2009.01347.x 1:CAS:528:DC%2BD1MXhsFOltrnO
51. A Kazantseva A Goltsov R Zinchenko AP Grigorenko AV Abrukova YK Moliaka AG Kirillov Z Guo S Lyle EK Ginter EI Rogaev 2006 Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH Science 314 982 985 17095700 10.1126/science.1133276 1:CAS:528:DC%2BD28XhtFyqtLnJ
52. M Tariq M Ayub M Jelani S Basit G Naz N Wasif SI Raza AK Naveed S ullah Khan Z Azeem M Yasinzai A Wali G Ali MS Chishti W Ahmad 2009 Mutations in the P2RY5 gene underlie autosomal recessive hypotrichosis in 13 Pakistani families Br J Dermatol 160 1006 1010 19292720 10.1111/j.1365-2133.2009.09046.x 1:CAS:528:DC%2BD1MXlvFOisrc%3D
53. S Shinkuma M Akiyama A Inoue J Aoki K Natsuga T Nomura K Arita R Abe K Ito H Nakamura H Ujiie A Shibaki H Suga Y Tsunemi W Nishie H Shimizu 2010 Prevalent LIPH founder mutations lead to loss of P2Y5 activation ability of PA-PLA1 alpha in autosomal recessive hypotrichosis Hum Mutat 31 602 610 20213768 1:CAS:528:DC%2BC3cXnt1Cjtb0%3D
54. RC Davis H Wong J Nikazy K Wang Q Han MC Schotz 1992 Chimeras of hepatic lipase and lipoprotein lipase. Domain localization of enzyme-specific properties J Biol Chem 267 21499 21504 1400461 1:CAS:528:DyaK38Xls1Klsb4%3D
55. ML Jennens ME Lowe 1995 C-terminal domain of human pancreatic lipase is required for stability and maximal activity but not colipase reactivation J Lipid Res 36 1029 1036 7658150 1:CAS:528:DyaK2MXlvFamt7w%3D
56. K Harper D Arsenault S Boulay-Jean A Lauzier F Lucien CM Dubois 2010 Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation Cancer Res 70 4634 4643 20484039 10.1158/0008-5472.CAN-09-3813 1:CAS:528:DC%2BC3cXmslWgtLY%3D
57. Z Lee CT Cheng H Zhang MA Subler J Wu A Mukherjee JJ Windle CK Chen X Fang 2008 Role of LPA4/p2y9/GPR23 in negative regulation of cell motility Mol Biol Cell 19 5435 5445 18843048 10.1091/mbc.E08-03-0316 1:CAS:528: DC%2BD1cXhsVynu77K
58. K Scotlandi D Remondini G Castellani MC Manara F Nardi L Cantiani M Francesconi M Mercuri AM Caccuri M Serra S Knuutila P Picci 2009 Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome J Clin Oncol 27 2209 2216 19307502 10.1200/JCO.2008.19.2542 1:CAS:528:DC%2BD1MXlvFOgs78%3D